Status:
UNKNOWN
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
Lead Sponsor:
University of Aleppo
Collaborating Sponsors:
Aleppo University Hospital
Conditions:
Basal Cell Carcinoma
BCC
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The investigators want to assess the safety and efficacy of using intralesional 5-FU for the management of different types of BCC (including all the types EXCEPT the infiltrative one), by estimating d...
Detailed Description
Brief Description: The investigatorswant to assess the safety and efficacy of using intralesional 5-FU for the management of different types of BCC (including all the types EXCEPT the infiltrative one...
Eligibility Criteria
Inclusion
- 5 Years to 90 Years (Child, Adult, Older Adult).
- Volunteer to participate in study
- Superficial lesion
- Nodular lesion (x ≤ 1.5 cm) patients are seen at the outpatient Department or in the dermatology wards at Aleppo University Hospital (AUH) over 12 months' period.
Exclusion
- Ulcerative.
- Nodular lesion (x ≥ 1.5 cm)
Key Trial Info
Start Date :
May 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 25 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06150144
Start Date
May 25 2023
End Date
May 25 2025
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ibrahim Arnaout
Aleppo, Syria